An Unbiased View of ML-210
Doable predictive biomarkers for tumor response to mTOR inhibitors, as are actually described in glioblastoma, breast and prostate cancer cells, may be the differential expression of mTOR pathway proteins, PTEN, AKT, and S6.[one] Therefore, this data is based on preclinical assays, based upon in vit